| HbA1c |
93.5 |
93.7 |
0.45 |
| Lipid profile |
71.5 |
71.8 |
0.47 |
| Blood pressure |
75.8 |
76.3 |
0.34 |
| Renal function |
50.8 |
51.4 |
0.27 |
| Eye examination |
41.0 |
41.3 |
0.55 |
| Favorable outcome indicators |
|
|
|
| HbA1c ≤7.0% (≤53 mmol/mol) |
25.6 |
20.4 |
<0.0001 |
| LDL-C <100 mg/dl |
41.4 |
41.5 |
0.91 |
| BP ≤130/80 mmHg |
61.5 |
69.5 |
<0.0001 |
| Unfavorable outcome indicators |
|
|
|
| HbA1c >8.0% (>64 mmol/mol) |
41.6 |
47.3 |
<0.0001 |
| LDL-C ≥130 mg/dl |
22.1 |
20.7 |
0.02 |
| BP ≥140/90 mmHg |
31.5 |
25.2 |
<0.0001 |
| BMI ≥30 Kg/m2 |
8.7 |
9.8 |
0.002 |
| GFR ≤60 ml/min |
7.8 |
9.6 |
<0.0001 |
| MAU |
30.1 |
24.7 |
<0.0001 |
| Indicators of treatment intensity/appropriateness |
|
|
|
| No lipid-lowering agents despite LDL-c ≥130 mg/dl |
68.2 |
71.1 |
0.04 |
| No antihypertensive treatments despite BP ≥140/90 mmHg |
49.8 |
47.4 |
0.06 |
| No ACE-I and/or ARBs despite MAU |
8.7 |
8.9 |
0.58 |
| LDL-c ≥130 mg/dl in spite of lipid-lowering treatment |
23.1 |
21.7 |
0.22 |
| BP ≥140/90 mmHg in spite of antihypertensive treatment |
50.8 |
47.6 |
0.01 |
| Overall quality of care |
|
|
|
| Q score <15 |
7.5 |
7.6 |
0.68 |
| Q score >25 |
40.6 |
41.5 |
0.14 |
